Intellectual Property Status

BioAxone’s technology is protected by several patent families that cover its products, delivery and therapeutic uses. These include the C3 based Rho GTPase inhibitor proteins with their proprietary transport enhancement peptide as well as the novel small molecule Rho kinase inhibitors.


 

© BioAxone Thérapeutique Inc. 2005